MIM Symphony®
Reshaping the Role of MRI in Brachytherapy
Reshaping the Role of MRI in Brachytherapy
MRI has the potential to substantially improve patient care. Are you aware of the key elements that ensure successful adoption and implementation?
Dose to the bladder neck, external urethral sphincter2, and neurovascular bundles may impact complications related to urinary toxicity and sexual function.
MRI-based plans provide a more accurate prediction for post-op dosimetry than US-based planning.
“How do we implement MRI-guided Brachytherapy?”
“How do we account for orientation differences and register the MRI to our ultrasound?”
“How do we incorporate MRI without extending OR time?”
Provides seamless MRI to ultrasound registration.
Guides you to eliminate misalignments and deformation errors during ultrasound acquisition.
Full treatment planning platform for MR or US-based planning with the same platform and tools as MIM Maestro®.
Using MRI provides the ability to boost dose to the MRI-visible lesion and enables more conformal dosimetry, resulting in improved cancer control with fewer complications.
Enables localization and real-time QA of the lesion using registrations.
Establishes a relationship between MRI-visible lesions and catheter placements.
Provides a reproducible process with automated tools for guidance during procedures.
MIM Symphony is a general purpose Brachytherapy platform. While prostate is an important treatment site, MIM supports a variety of treatments either directly or with our strategic partners.
Treatment Planning
MR/US guidance
From chart rounds to physician contouring meetings, does your peer review process align with your quality assurance goals?
A reliable remote connection is more important now than ever. Is working remotely working for you?
Your pre-planning workflow involves many tasks and clinicians. Are you doing everything you can to set yourself up for a quality treatment plan?
Consider how your daily workflow is limited by current methods.
Copyright © 2023 MIM Software Inc. All Rights Reserved.